Xiucheng Pan

6PUBLICATIONS
17CO-AUTHORS
Haematological tumoursRespiratory diseasesPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2025
HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.

Fanyun Kong, Ensi Bao, Yujie Zhong

|Oct 29, 2024
Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First-Time HBV-Related Decompensated Cirrhosis.

Xinxin Rong, Guangde Yang, Yuanyuan Xu

|Jul 09, 2024
The Impact of Proton Pump Inhibitors on the Efficacy of Immune Checkpoint Inhibitor Combinations in Patients with HBV-Associated Advanced Hepatocellular Carcinoma.

Ningning Wang, Yuanyuan Xu, Guangde Yang

|Feb 24, 2023
Development and validation of a nomogram to predict recompensation in HBV-related cirrhosis with ascites as the single first decompensating event.

Shifei Wen, Jiajia Ruan, Jiaming Shen

|Feb 08, 2019
Tim-3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B.

Junyan Wang, Chan Li, Juanjuan Fu

|Dec 06, 2018
VDR rs7975232/ApaI genetic variation predicts sustained HBsAg loss in HBeAg-positive chronic hepatitis B patients treated with pegylated interferon.

Ben Shan, Jun Yan Wang, Xia Wang

Pageof 1

Frequent Collaborators

1 joint publications

Ben Shan

1 joint publications

Ningning Wang

1 joint publications

Xinxin Rong

1 joint publications

Fanyun Kong